Teva Pharmaceutical Industries (TEVA) Restructuring Costs (2009 - 2013)
Teva Pharmaceutical Industries' (TEVA) quarterly Restructuring Costs came in at $47.0 million in Q3 2013, down 93.18% on a YoY basis from $689.0 million in Q3 2012, and down 96.72% quarter-over-quarter from $1.4 billion in Q2 2013.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Restructuring Costs (2009 - 2013) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Restructuring Costs for 4 consecutive years, with $47.0 million the latest figure, recorded in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.76 Bn | 39.10 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.52 Bn | 5.39 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 545.13 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.46 Mn | 702.34 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 409.53 Mn | 368.28 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.80 Mn | 179.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 47.00 Mn |
| Jun 30, 2013 | 1.44 Bn |
| Mar 31, 2013 | 41.00 Mn |
| Sep 30, 2012 | 689.00 Mn |
| Jun 30, 2012 | 21.00 Mn |
| Mar 31, 2012 | 40.00 Mn |
| Sep 30, 2011 | 36.00 Mn |
| Sep 30, 2009 | 97.00 Mn |
| Jun 30, 2009 | 52.00 Mn |
| Mar 31, 2009 | 14.00 Mn |